Mostra el registre parcial de l'element
dc.contributor.author | Garcia Llorens, Guillem | |
dc.contributor.author | Lopez Navarro, Sergi | |
dc.contributor.author | Jaijo, Teresa | |
dc.contributor.author | Castell, José V. | |
dc.contributor.author | Bort Martí, Roque | |
dc.date.accessioned | 2023-05-31T11:38:07Z | |
dc.date.available | 2023-05-31T11:38:07Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Garcia Llorens, Guillem Lopez Navarro, Sergi Jaijo, Teresa Castell Ripoll, José Vicente Bort Martí, Roque 2022 Modeling a Novel Variant of Glycogenosis IXa Using a Clonal Inducible Reprogramming System to Generate "Diseased" Hepatocytes for Accurate Diagnosis. Journal Of Personalized Medicine 12 7 1 11 | |
dc.identifier.uri | https://hdl.handle.net/10550/87188 | |
dc.description.abstract | The diagnosis of inherited metabolic disorders is a long and tedious process. The matching of clinical data with a genomic variant in a specific metabolic pathway is an essential step, but the link between a genome and the clinical data is normally difficult, primarily for new missense variants or alterations in intron sequences. Notwithstanding, elucidation of the pathogenicity of a specific variant might be critical for an accurate diagnosis. In this study, we described a novel intronic variant c.2597 + 5G > T in the donor splice sequence of the PHKA2 gene. To investigate PHKA2 mRNA splicing, as well as the functional consequences on glycogen metabolism, we generated hepatocyte-like cells from a proband's fibroblasts by direct reprogramming. We demonstrated an aberrant splicing of PHKA2, resulting in the incorporation of a 27 bp upstream of intron 23 into exon 23, which leads to an immediate premature STOP codon. The truncated protein was unable to phosphorylate the PYGL protein, causing a 4-fold increase in the accumulation of glycogen in hepatocyte-like cells. Collectively, the generation of personalized hepatocyte-like cells enabled an unequivocal molecular diagnosis and qualified the sister's proband, a carrier of the same mutation, as a candidate for a preimplantation genetic diagnosis. Additionally, our direct reprogramming strategy allows for an unlimited source of "diseased" hepatocyte-like cells compatible with high-throughput platforms. | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal Of Personalized Medicine, 2022, vol. 12, num. 7, p. 1-11 | |
dc.subject | Bioquímica | |
dc.subject | Biologia | |
dc.title | Modeling a Novel Variant of Glycogenosis IXa Using a Clonal Inducible Reprogramming System to Generate "Diseased" Hepatocytes for Accurate Diagnosis. | |
dc.type | journal article | |
dc.date.updated | 2023-05-31T11:38:07Z | |
dc.identifier.doi | 10.3390/jpm12071111 | |
dc.identifier.idgrec | 159555 | |
dc.rights.accessRights | open access |